Skip to main content

Dana-Farber Cancer Institute


The following description was provided by the Dana-Farber Cancer Institute:

Ever since Sidney Farber, MD, pioneered chemical therapies to treat children with leukemia in 1947, Dana-Farber has forged a groundbreaking path: 70+ years of research discovery and innovation have revolutionized cancer diagnosis and treatment, for the benefit of all their patients, adult and pediatric. Dana-Farber's equal emphasis on patient care and research means that their leading-edge research is informed by patient care – and their patient care relies on leading-edge research.

Browse available plasmids from each Dana-Farber PI listed below.

Resources

Dana-Farber Cancer Institute Sharing Statistics

50 Depositing Scientists

Sharing 2,551 Reagents

Requested 63,774 Times

Shipped to 76 Countries

Depositing Principal Investigators (PIs)